Panacea Index Logo

Command Palette

Search for a command to run...

Benefits of regular walking exercise in advanced pre-dialysis chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
March 1, 2012
George C Kosmadakis et al. (10 authors)
Comparative StudyJournal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine whether additional oral sodium bicarbonate (target venous bicarbonate 29 mmol/L) provided benefits compared to standard treatment (target 24 mmol/L) in pre-dialysis CKD patients.

Results Summary

Sodium bicarbonate supplementation did not produce any significant alterations in outcomes compared to standard treatment. The study found no notable benefits or harms from the intervention.

Population

Pre-dialysis patients with CKD Stages 4 and 5.

Effective Dosage

Target venous bicarbonate levels of 29 mmol/L (intervention) vs. 24 mmol/L (standard).

Duration

6 months.

Interactions

None mentioned.

Extracted Claims (8)
InterventionDirectionEndpointPopulationDosageImpactClaim #
regular walking
increase
exercise tolerance
pre-dialysis patients with CKD Stages 4 and 5
-
improvements in
#1
regular walking
decrease
exercise tolerance
pre-dialysis patients with CKD Stages 4 and 5
-
reduced exertion to achieve the same activity
#2
regular walking
decrease
body weight
pre-dialysis patients with CKD Stages 4 and 5
-
weight loss
#3
regular walking
increase
cardiovascular reactivity
pre-dialysis patients with CKD Stages 4 and 5
-
improved
#4
regular walking
no change
blood pressure medication
pre-dialysis patients with CKD Stages 4 and 5
-
avoiding an increase in
#5
regular walking
increase
quality of health and life
pre-dialysis patients with CKD Stages 4 and 5
-
improvements in
#6
regular walking
increase
uraemic symptom scores
pre-dialysis patients with CKD Stages 4 and 5
-
improvements in
#7
sodium bicarbonate supplementation
no change
-
pre-dialysis patients with CKD Stages 4 and 5
-
did not produce any significant alterations
#8
Abstract

BACKGROUND: There is increasing evidence of the benefit of regular physical exercise in a number of long-term conditions including chronic kidney disease (CKD). In CKD, this evidence has mostly come from studies in end stage patients receiving regular dialysis. There is little evidence in pre-dialysis patients with CKD Stages 4 and 5. METHODS: A prospective study compared the benefits of 6 months regular walking in 40 pre-dialysis patients with CKD Stages 4 and 5. Twenty of them were the exercising group and were compared to 20 patients who were continuing with usual physical activity. In addition, the 40 patients were randomized to receive additional oral sodium bicarbonate (target venous bicarbonate 29 mmol/L) or continue with previous sodium bicarbonate treatment (target 24 mmol/L). RESULTS: Improvements noted after 1 month were sustained to 6 months in the 18 of 20 who completed the exercise study. These included improvements in exercise tolerance (reduced exertion to achieve the same activity), weight loss, improved cardiovascular reactivity, avoiding an increase in blood pressure medication and improvements in quality of health and life and uraemic symptom scores assessed by questionnaire. Sodium bicarbonate supplementation did not produce any significant alterations. CONCLUSIONS: This study provides further support for the broad benefits of aerobic physical exercise in CKD. More studies are needed to understand the mechanisms of these benefits, to study whether resistance exercise will add to the benefit and to evaluate strategies to promote sustained lifestyle changes, that could ensure continued increase in habitual daily physical activity levels.

Medical Subject Headings (MeSH)
AdultAgedAged, 80 and overBlood PressureCase-Control StudiesEnergy MetabolismExercise TherapyFemaleHumansKidney Failure, ChronicMaleMiddle AgedPrognosisProspective StudiesQuality of LifeRenal DialysisSurveys and QuestionnairesWalkingYoung Adult
Study Links
Quality Scores
SafetyNot Assessed
Efficacy30/10
Quality75/10
Citation Metrics
Total Citations66
Citations/Year5.1
Relative Citation Ratio2.21
NIH Percentile77.5%
Research Impact Scores
APT Score0.95
Weight Score1.49
Normalized Score0.47
Related Supplements